V. T. Perchyonok / Tetrahedron Letters 47 (2006) 5163–5165
5165
Han, X.; Hartmann, G. A.; Brazzale, A.; Gaston, R. D.
Tetrahedron Lett. 2001, 42, 5837.
kC
TMS3C
Br
5. (a) Lusztyk, J.; Maillard, B.; Lindsay, D. A.; Ingold, K. U.
J. Am. Chem. Soc. 1983, 105, 3578; For reductive radical
chain reactions using Bu3GeH see: (b) Pike, P.; Hersh-
berger, S.; Hershberger, J. Tetrahedron 1988, 44, 6295;
Bowman, R. W.; Krintel, S. L.; Schilling, M. B. Synlett
2004, 1215; Pedersen, J. M.; Bowman, R. W.; Elsegood,
M. R. J.; Fletcher, A. J.; Lovell, P. J. J. Org. Chem. 2005,
70(25), 10617; For examples of Ph3GeH in preparative
radical chemistry see: (c) Gupta, V.; Kahne, D. Tetra-
hedron Lett. 1993, 34, 591; (d) Bowman, R. W.; Krintel, S.
L.; Schilling, M. B. Org. Biomol. Chem. 2004, 2, 585–592.
6. For examples on uses of 1-ethylpiperidine phosphite (1-
ETHP) see: (a) Martin, C. G.; Murphy, J. A.; Smith, C. R.
Tetrahedron Lett. 2000, 41, 1833; (b) Graham, S. R.;
Murphy, J. A.; Kennedy, A. R. J. Chem. Soc., Perkin.
Trans. 1 1999, 3071; For examples of uses and kinetic data
associated with diethylphosphine oxide see: Chatgilia-
loglu, C.; Timokhin, V. I.; Ballestri, M. J. Org. Chem.
1998, 63, 1327.
8
TMS3CH
kH
TMS3CH
9
10
Scheme 2.
Table 3. Rate constants for the hydrogen transfer from TMS3CH
(0.09 M) to primary radical in comparison with alternative hydrogen
donors at 70 ꢁC
Entry
H-donor
10ꢀ5 kH/Mꢀ1 sꢀ1
Reference
1
2
3
4
(Me3Si)3SiH
Et3SiH
(Me3Si)3CH
Bu3SnH
11
7
7. There are some examples using i-PrOH as the reducing
reagent in radical reaction however these processes are not
chain reactions: (a) Liard, A.; Quiclet-Sire, B.; Zard, S. Z.
Tetrahedron Lett. 1998, 39, 9435; Et2O as a C–H reductant
in non-chain radical reactions: (b) Matsumoto, A.; Ito, Y.
J. Org. Chem. 2000, 65, 5707; (c) Quiclet-Sire, B.; Zard, S.
Z. J. Am. Chem. Soc. 1996, 118, 9190.
0.04
2.5
24
10
twa
11a
a tw, Signifies this work, average of three experiments.
8. Typical reduction procedure is as follows: (TMS)3CH
(2 equiv) and the radical precursor (1 equiv) were dis-
solved in benzene (50 lL). A pyrex tube was charged with
the required solution (300 lL) and AIBN (0.5 equiv)
added. The solution was frozen in liquid nitrogen, sealed
under vacuum and heated in the 80 ꢁC constant temper-
ature oil bath overnight. The reaction mixture was then
analyzed by GC. Chromatography column used in inves-
tigation: trifluoroacetylated c-cyclodextrin (ChiraldexTM
G-TA 30 m · 0.25 mm) capillary column purchased from
Alltech.
In summary (TMS)3CH is a highly-efficient, tin-free,
radical reducing agent, which is compatible with
standard radical precursor systems. Kinetic experiments
as well as some preliminary computational evidence
point towards (TMS)3CH being a versatile and environ-
ment friendly addition to the toolkit of organic chemists.
We are currently investigating further the scope and
limitations in the use of the (TMS3)CH in radical
cascade reactions.
9. The typical procedure for the preparative scale reactions is
as follows: To a solution of freshly recrystallized xantate
derived from dihydrocholestane (0.1 M) in dry benzene
(5 ml), tris(trimethylsilyl)methane (2 equiv) was added. At
that stage reaction mixture was degassed using freeze-
pump-thaw technique. AIBN was added (0.5 equiv) at
room temperature and the degassing cycle repeated again
at room temperature and liquid nitrogen. Reaction mix-
ture was allowed to be heated at the constant temperature
(80 ꢁC) oil bath for 12 h under the atmosphere of dry N2.
Excess of solvent was removed in vacuo and the crude
reaction mixture analyzed by 1H, 13C NMR, revealed
complete conversion of the starting material to the desired
product. Cholestane (72%) was isolated as a white solid
after recrystallization from diethyl ether/ethanol.
References and notes
1. For reviews, see: (a) Neumann, W. P. Synthesis 1987, 665;
(b) Pereyre, M.; Quintard, J.-P.; Rahm, A. Tin in Organic
Synthesis; Butterworth: London, 1987; (c) RajanBabu, T.
V. In Encyclopedia of Reagents for Organic Synthesis;
Paquette, L., Ed.; Wiley: New York, 1995; Vol. 7, p 5016.
2. (a) Ingham, R. K.; Rosenberg, S. D.; Gilman, H. Chem.
Rev. 1960, 60, 459; (b) Boyer, I. J. Toxicol. 1989, 55, 253.
3. (a) Baguley, P. A.; Walton, J. C. Angew. Chem. 1998, 110,
3272; (b) Baguley, P. A.; Walton, J. C. Angew. Chem.
1998, 110, 3072; (c) Chatgilialoglu, C. Acc. Chem. Res.
1992, 25, 188; (d) Sugi, M.; Togo, H. Tetrahedron 2002,
58, 3171, and references cited therein; (e) Studer, A.;
Amrein, S. Synthesis 2002, 835.
1H (NMR) CDCl3: d 0.4–2.0 (46H, m), 13C (NMR)
CDCl3: d 57.7, 57.3, 55.8, 48.1, 43.7, 41.2, 40.6, 39.8, 37.3,
37.2, 36.9, 36.6, 33.7, 30.2, 30.1, 29.3, 29.1, 27.9, 25.3, 24.9,
23.9, 23.6, 23.3, 21.9, 19.7, 13.3, 13.1.
4. (a) Curran, D. P. Angew. Chem. Int. Ed. 1998, 37, 1175; .
Angew. Chem. 1998, 110, 1230; (b) Light, J.; Breslow, R.
Tetrahedron Lett. 1990, 31, 2957; (c) Vedejs, E.; Duncan,
S. M.; Haight, A. R. J. Org. Chem. 1993, 58, 3046; (d)
Clive, D. L. J.; Yang, W. J. Org. Chem. 1995, 60, 2607; (e)
10. Keck, G. Y.; Burnett, D. A. J. Org. Chem. 1987, 52, 2958.
11. Griller, D.; Ingold, K. U. Acc. Chem. Res. 1980, 13, 317,
and references cited therein.